Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: It is controversial whether iRECIST has a significant impact over RECIST 1.1 in evaluating the efficacy of immune checkpoint inhibitor treatment. We aimed to evaluate the impact of iRECIST on assessing treatment efficacy of immune checkpoint inhibitors over RECIST 1.1 through a syste...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Park, Hyo Jung, Kim, Gun Ha, Kim, Kyung Won, Lee, Choong Wook, Yoon, Shinkyo, Chae, Young Kwang, Tirumani, Sree Harsha, Ramaiya, Nikhil H.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Systematic Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795764/
https://ncbi.nlm.nih.gov/pubmed/33561078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010120
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky